Truist raises Texas Instruments stock price target on demand recovery By Investing.com

TXN is being repriced less on the reported beat than on the market’s willingness to pay for a higher-quality cyclical recovery. The key second-order effect is that broadening demand from AI/datacenter into industrials reduces the risk of a single-end-market air pocket, but it also caps upside because analog recovery is now becoming visible to everyone, not just a handful of channel checks. When consensus shifts from “depressed cycle” to “normalized cycle,” multiple expansion tends to stall before earnings growth does.

The relative winner here is not necessarily TXN; it is the lower-quality analog/industrial suppliers that still have margin catch-up ahead of them. If Truist is right that suppliers with less recovered margins will show stronger operating leverage, then TXN may actually be the benchmark that others use to justify higher targets across the group, while the best total-return trade may sit in names with more torque to utilization and pricing rather than the highest current quality.

Near term, the main risk is that the current upgrade wave becomes a valuation event rather than an earnings event. Over the next 1-3 months, any sign that industrial demand is merely restocking rather than end-demand would pressure the multiple, especially after a strong multi-quarter run. Over 6-12 months, the bear case is that TXN’s cash-flow durability remains intact but the stock underperforms if earnings revisions flatten and investors rotate toward faster-margin-recovery names.

Contrarian view: the market may be over-anchoring on the ‘broadening recovery’ narrative and underestimating how much of the upside is already in the stock. A 32x forward multiple implies very little room for execution slippage, so the better asymmetry may be to fade TXN strength relative to peers with lower starting multiples and more operating leverage.